Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
Clinical trial NCT00915187 · COMPLETED
Trial details
- NCT number
- NCT00915187
- Sponsor
- NasVax Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.